Global Gastrointestinal Drugs Market Research Report: Information by Drug Class (Acid Neutralizers, Anti-Inflammatory Drugs, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Biologics and others), Route of Administration (Oral, Parenteral and Rectal), Application (Inflammatory Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Gastroenteritis and others), Distribution Channel (Retail Pharmacies, Online Pharmacies and Hospital Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

ID: MRFR/Pharma/0115-HCR | February 2021 | Region: Global | 90 pages

Gastrointestinal Drugs Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 42,180 Million in 2018 and is projected to register a valuation of USD 59,300 Million by 2025, with a CAGR of 4.9% over the forecast period., The increasing prevalence of gastrointestinal diseases and rising investments and funding in the field of life science research are likely to provide favorable conditions for the growth of the market during the forecast period. , Various other factors, such as the changing lifestyle and increasing number of geriatric individuals, are also expected to propel the growth of the market., However, high raw material costs and growing presence of counterfeit drugs can hamper market growth over the forecast period., Segmentation, The global gastrointestinal drugs market is segmented based on drug class, route of administration, application, distribution channel, and region. , The global market for gastrointestinal drugs, by drug class, is segmented into acid neutralizers, anti-inflammatory drugs, antidiarrheal and laxatives, antiemetic and antinauseants, biologics, and others. , Based on route of administration, the market is segmented into oral, parenteral, and rectal., Based on Application, the market is segmented into inflammatory ulcerative colitis, irritable bowel syndrome, Crohn's disease, celiac disease, gastroenteritis, and others., Distribution channels are segmented into retail pharmacies, online pharmacies, and hospital pharmacies., In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa., The gastrointestinal drugs market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada., The European gastrointestinal drugs market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The gastrointestinal drugs market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The gastrointestinal drugs market in the Middle East & Africa has been segmented into the Middle East and Africa., Regional Market Summary, Global Gastrointestinal Drugs Market Share (%), by Region, 2018, , Sour

Market Scenario

Gastrointestinal Drugs Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 42,180 Million in 2018 and is projected to register a valuation of USD 59,300 Million by 2025, with a CAGR of 4.9% over the forecast period.

The increasing prevalence of gastrointestinal diseases and rising investments and funding in the field of life science research are likely to provide favorable conditions for the growth of the market during the forecast period.

Various other factors, such as the changing lifestyle and increasing number of geriatric individuals, are also expected to propel the growth of the market.

However, high raw material costs and growing presence of counterfeit drugs can hamper market growth over the forecast period.

Segmentation

The global gastrointestinal drugs market is segmented based on drug class, route of administration, application, distribution channel, and region.

The global market for gastrointestinal drugs, by drug class, is segmented into acid neutralizers, anti-inflammatory drugs, antidiarrheal and laxatives, antiemetic and antinauseants, biologics, and others.

Based on route of administration, the market is segmented into oral, parenteral, and rectal.

Based on Application, the market is segmented into inflammatory ulcerative colitis, irritable bowel syndrome, Crohn's disease, celiac disease, gastroenteritis, and others.

Distribution channels are segmented into retail pharmacies, online pharmacies, and hospital pharmacies.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The gastrointestinal drugs market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European gastrointestinal drugs market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The gastrointestinal drugs market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The gastrointestinal drugs market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Gastrointestinal Drugs Market Share (%), by Region, 2018

Sources: MRFR Analysis

The Americas dominated the global market for gastrointestinal drugs owing to the increasing digestive disorders, increasing healthcare expenditure, and presence of well-established healthcare sector in the region. According to the report published by the US Department of Health & Human Services, more than 15.3 million Americas were affected by ulcer in 2017, which is around 6.2% of total adult population. In 2018, it was estimated that Europe stood second in the gastrointestinal drugs market. The increasing awareness about digestive diseases, increasing investments in the healthcare industry in the region, and growing demand for efficient treatment solutions for gastrointestinal disorders is expected to drive the growth of the market. Germany held the largest share of the market for gastrointestinal drugs in the region.

Asia-Pacific (APAC) is expected to witness the fastest growth in the gastrointestinal drugs market throughout the forecast period due to the rising geriatric population, presence of a large patient pool, and increasing government initiatives for the growth of the healthcare sector in the region. Countries in Asia-Pacific are adopting advanced treatment options, which in turn fuels the market growth in this region. Moreover, presence of developing countries, such as China, India, and Japan, is expected to drive the market growth in the region.

On the other hand, the Middle East & Africa is expected to hold the least share of the gastrointestinal drugs market due to the low economic development, especially in Africa.

Key Players

Some of the Key Players operating in the Global Gastrointestinal Drugs Market are Takeda Pharmaceuticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, AbbVie Inc., Valeant Pharmaceuticals Inc., Johnson & Johnson, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., Janssen Biotech Inc., and Sanofi.

Market Segmentation

Global Gastrointestinal Drugs Market, by Drug Class

Acid Neutralizers
- Antacids
- H2 Antagonists
- Proton Pump Inhibitors

Anti-inflammatory Drugs

Antidiarrheal and Laxatives

Antiemetic and Antinauseants

Biologics

Others

Global Gastrointestinal Drugs Market, by Route of Administration

Oral

Parenteral

Rectal

Global Gastrointestinal Drugs Market, by Application

Inflammatory Ulcerative Colitis

Irritable Bowel Syndrome

Crohn's Disease

Celiac Disease

Gastroenteritis

Others

Global Gastrointestinal Drugs Market, by Distribution Channel

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Intended Audience

Gastrointestinal drugs manufacturing companies

Healthcare organizations

Healthcare providers

Government organizations

Biotechnology companies

Research and development (R&D) companies

Frequently Asked Questions (FAQ) :

What is the projected valuation of the global gastrointestinal drugs market?

Gastrointestinal drugs market valuation can touch USD 59,300 million by 2025.

What is the expected growth rate of the global gastrointestinal drugs market?

Gastrointestinal drugs market is expected to exhibit a CAGR of 4.9% from 2019 to 2025.

What is the major driver of the global gastrointestinal drugs market?

Gastrointestinal drugs market is driven by the alarming cases of GI among the masses.

What factors can restrain the global gastrointestinal drugs market growth?

Presence of counterfeit drugs and high raw material costs can restrain the global gastrointestinal drugs market growth.

Name the prominent players of the gastrointestinal drugs market.

GlaxoSmithKline Plc., Janssen Biotech Inc., Johnson & Johnson, Valeant Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Takeda Pharmaceuticals, Allergan Plc, Bayer AG, Sanofi, AstraZeneca Plc, Novo Nordisk A/S, and AbbVie Inc. are major players of the global gastrointestinal drugs market.

Table of Contents:

Chapter 1. Executive Summary

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D and Designing

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Review

Chapter 6. Global Gastrointestinal Drugs Market, by Drug Class

6.1 Overview

6.2 Acid Neutralizers

6.2.1 Antacids

Market Estimates & Forecast, by Region, 2019–2025